vidarabine phosphate has been researched along with Agranulocytosis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastion, Y; Bordessoule, D; Bosly, A; Brice, P; Brousse, N; Caspard, H; Dupas, B; Fort, N; Haïoun, C; Harousseau, JL; Leporrier, M; Morel, P; Plassart, F; Sebban, C; Solal-Céligny, P; Tilly, H; Vasile, N | 1 |
| Bonnet, JD; Crowley, JJ; Grever, MR; Hynes, HE; Keppen, MD; Kraut, EH; Salmon, SE | 1 |
| Bodey, GP; Kavanagh, JJ; Krakoff, IH | 1 |
| Clark, G; Hersh, MR; Kuhn, JG; Ludden, TM; Phillips, JL; Von Hoff, DD | 1 |
| Alberts, DS; Hutton, JJ; Kronmal, R; O'Toole, RV; Surwit, EA; Von Hoff, DD | 1 |
1 trial(s) available for vidarabine phosphate and Agranulocytosis
| Article | Year |
|---|---|
Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: a multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Disease-Free Survival; Female; Humans; Lymphoma, Follicular; Male; Middle Aged; Treatment Outcome; Vidarabine Phosphate | 1996 |
4 other study(ies) available for vidarabine phosphate and Agranulocytosis
| Article | Year |
|---|---|
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group study.
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Drug Administration Schedule; Drug Evaluation; Humans; Middle Aged; Multiple Myeloma; Vidarabine Phosphate | 1990 |
Phase I study of fludarabine (2-fluoro-ara-AMP).
Topics: Adult; Aged; Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Breast Neoplasms; Choriocarcinoma; Drug Evaluation; Female; Humans; Middle Aged; Pregnancy; Rhabdomyosarcoma; Sarcoma, Ewing; Thrombocytopenia; Uterine Cervical Neoplasms; Uterine Neoplasms; Vidarabine Phosphate | 1985 |
Pharmacokinetic study of fludarabine phosphate (NSC 312887).
Topics: Agranulocytosis; Antimetabolites, Antineoplastic; Arabinonucleotides; Biotransformation; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Vidarabine Phosphate | 1986 |
Phase II study of fludarabine phosphate (NSC-312887) in patients with advanced ovarian cancer. A Southwest Oncology Group Study.
Topics: Adult; Aged; Agranulocytosis; Antineoplastic Agents; Arabinonucleotides; Drug Evaluation; Female; Humans; Infusions, Intravenous; Middle Aged; Ovarian Neoplasms; Vidarabine Phosphate | 1988 |